Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples